Completed PHASE4 INTERVENTIONAL 2-arm NCT04266288

Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department

Rapid Antidepressant Response to Ketamine and Impact on Healthcare Utilization After Administration in the Emergency Department

Sponsor: MercyOne Des Moines Medical Center

Conditions Depression Depression Acute Depression Severe Depression and Suicide Suicidal Ideation

Interventions Ketamine Sodium Chloride 0.9%

Updated 5 times since 2020 Last updated: Aug 31, 2020 Started: Oct 18, 2019 Primary completion: May 31, 2020 Completion: May 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Depression and Depression Acute and is currently completed. MercyOne Des Moines Medical Center leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Oct 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Enrolling By Invitation → Completed
Mar 2020 — Oct 2020 [monthly]

Enrolling By Invitation PHASE4

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MercyOne Des Moines Medical Center

Data source: MercyOne Des Moines Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Des Moines, United States